Pharmacokinetics and bioequivalence of two different 20 mg olmesartan tablets: A randomized, single-dose, two-period crossover study in healthy Korean male volunteers-Reference-Cited by-同舟云学术

Pharmacokinetics and bioequivalence of two different 20 mg olmesartan tablets: A randomized, single-dose, two-period crossover study in healthy Korean male volunteers

Published:2015 Issue:2 Volume:23 Page:49
ISSN:2289-0882
Container-title:Translational and Clinical Pharmacology
language:en
Short-container-title:Transl Clin Pharmacol

Author:

Lee Jieon¹,Kim AnHye¹,Yu Kyung-Sang¹,Chung Jae-Yong²,Yim Sung-Vin³,Kim Bo-Hyung³

Affiliation:

1. Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul 03080, Korea.

2. Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Bundang Hospital, Seongnam 13620, Korea.

3. Department of Clinical Pharmacology and Therapeutics, Kyung Hee University College of Medicine and Hospital, Seoul 02447, Korea.

Funder

DongKoo Bio & Pharma., Co., Ltd

Publisher

Korean Society for Clinical Pharmacology and Therapeutics

Subject

Pharmacology (medical)

Link

https://synapse.koreamed.org/pdf/10.12793/tcp.2015.23.2.49

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. “Implementation of Quality by Design of Sublingual Antihypertensive Drugs";Journal of Pharmaceutical Innovation;2024-04-20

2. Investigation Planning and Bioequivalence evaluation of Angiotensin II Receptor Antagonists;Pharmaceutical Chemistry Journal;2019-11

3. Population Pharmacokinetic Modeling of Olmesartan, the Active Metabolite of Olmesartan Medoxomil, in Patients with Hypertension;European Journal of Drug Metabolism and Pharmacokinetics;2016-08-17